Why the study?
Does flosequinan affect ischaemia-induced arrhythmias and ventricular cyclic nucleotide content in anaesthetized rats following coronary artery ligation?
Does flosequinan affect ischaemia-induced arrhythmias and ventricular cyclic nucleotide content in anaesthetized rats following coronary artery ligation?
Flosequinan, unlike milrinone, isoprenaline, and forskolin, does not exacerbate ischaemia-induced arrhythmias or increase ventricular cyclic AMP in a rat model of coronary ligation.
Flosequinan shows arrhythmia neutrality in this rat model; leaves open translation to human ischaemic risk versus PDE inhibitors.
Flosequinan, milrinone, isoprenaline and forskolin given intravenously at similarly hypotensive doses have been evaluated in separate studies for their effect on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content following coronary artery ligation in the pentobarbitone anaesthetized rat. 2. Flosequinan did not affect mortality or arrhythmias following coronary artery ligation in either study and no change in ventricular cyclic nucleotide content was observed. 3. Isoprenaline caused a significant increase in mortality (P < 0.05) in both studies whereas milrinone and forskolin caused a significant increase in mortality in only one of the two studies conducted. All three agents caused significant increases in cyclic AMP which were associated with increased incidence of arrhythmias. 4. When compared at similarly hypotensive doses, flosequinan, in contrast to milrinone, isoprenaline and forskolin, did not influence ischaemia-induced arrhythmias or raise ventricular cyclic nucleotide levels in the anesthetized rat.
No takes yet. Share an insight, caveat, or question.
Jones et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: